E-LIB Suche - Ergebnisse für: de Jong, Amos J.

1

Opportunities and Challenges for Decentralized Clinical Tri..:

de Jong, Amos J. ; Shahid, Nadi ; Zuidgeest, Mira G.P....
Value in Health. 27 (2024) 3 - p. 294-300 , 2024

Link: https://doi.org/10.1016/..

2

Decentralised, patient-centric, site-less, virtual, and dig..:

Santa-Ana-Tellez, Yared ; Lagerwaard, Bart ; de Jong, Amos J....
Drug Discovery Today. 28 (2023) 4 - p. 103520 , 2023

Link: https://doi.org/10.1016/..

3

Direct‐to‐participant investigational medicinal product sup..:

de Jong, Amos J. ; Santa‐Ana‐Tellez, Yared ; Zuidgeest, Mira G. P....
British Journal of Clinical Pharmacology. 89 (2023) 12 - p. 3512-3522 , 2023

Link: https://doi.org/10.1111/..

4

Ethics review of decentralized clinical trials (DCTs): Resu..:

van Rijssel, Tessa I. ; de Jong, Amos J. ; Santa-Ana-Tellez, Yared...
Drug Discovery Today. 27 (2022) 10 - p. 103326 , 2022

Link: https://doi.org/10.1016/..

5

Which decentralised trial activities are reported in clinic..:

de Jong, Amos J ; Grupstra, Renske J ; Santa-Ana-Tellez, Yared...
BMJ Open. 12 (2022) 8 - p. e063236 , 2022

Link: https://doi.org/10.1136/..

6

Opportunities and Challenges for Decentralized Clinical Tri..:

de Jong, Amos J. ; van Rijssel, Tessa I. ; Zuidgeest, Mira G. P....
Clinical Pharmacology & Therapeutics. 112 (2022) 2 - p. 344-352 , 2022

Link: https://doi.org/10.1002/..

7

Predictive Value of Precision-Cut Kidney Slices as an Ex Vi..:

Bigaeva, Emilia ; Puerta Cavanzo, Nataly ; Stribos, Elisabeth G. D....
Pharmaceutics. 12 (2020) 5 - p. 459 , 2020

Link: https://doi.org/10.3390/..

8

Promoting system-level learning from project-level lessons:

de Jong, Amos A. ; Runhaar, Hens A.C. ; Runhaar, Piety R...
Environmental Impact Assessment Review. 33 (2012) 1 - p. 23-31 , 2012

Link: https://doi.org/10.1016/..

9

COVID‐19 and the Emerging Regulatory Guidance for Ongoing C..:

de Jong, Amos Jochanan ; Santa‐Ana‐Tellez, Yared ; van Thiel, Ghislaine José Madeleine Wilhelmien...
Clinical Pharmacology & Therapeutics. 109 (2021) 6 - p. 1517-1527 , 2021

Link: https://doi.org/10.1002/..

10

Which decentralised trial activities are reported in clinic..:

de Jong, Amos J ; Grupstra, Renske J ; Santa-Ana-Tellez, Yared...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438113/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Predictive Value of Precision-Cut Kidney Slices as an Ex Vi..:

Bigaeva, Emilia ; Puerta Cavanzo, Nataly ; Stribos, Elisabeth G. D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285118/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Predictive Value of Precision-Cut Kidney Slices as an Ex Vi..:

Bigaeva, Emilia ; Puerta Cavanzo, Nataly ; Stribos, Elisabeth G D...
https://research.rug.nl/en/publications/4de479cd-5e72-4808-896a-d4c8c7987bc3. , 2020

Link: https://hdl.handle.net/1..

13

Predictive value of precision-cut kidney slices as an ex vi..:

Bigaeva, Emilia ; Cavanzo, Nataly Puerta ; Stribos, Elisabeth G.D...
Bigaeva , E , Cavanzo , N P , Stribos , E G D , de Jong , A J , Biel , C , Mutsaers , H A M , Jensen , M S , Nørregaard , R , Leliveld , A M , de Jong , I J , Hillebrands , J L , van Goor , H , Boersema , M , Bank , R A & Olinga , P 2020 , ' Predictive value of precision-cut kidney slices as an ex vivo screening platform for therapeutics in human renal fibrosis ' , Pharmaceutics , vol. 12 , no. 5 , 459 . https://doi.org/10.3390/pharmaceutics12050459. , 2020

Link: https://pure.au.dk/porta..

14

COVID-19 and the Emerging Regulatory Guidance for Ongoing C..:

Jong, Amos Jochanan de ; Santa-Ana-Tellez, Yared ; Thiel, Ghislaine José Madeleine Wilhelmien van...
0009-9236. , 2021

Link: https://dspace.library.u..

15

Which decentralised trial activities are reported in clinic..:

Anthonius de Boer ; Helga Gardarsdottir ; Amos J de Jong...
https://bmjopen.bmj.com/content/12/8/e063236.full. , 2022

Link: https://doi.org/10.1136/..